Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies Emerging Risk Factors Collaboration The lancet 375 (9733), 2215-2222, 2010 | 6236 | 2010 |
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials N Sattar, D Preiss, HM Murray, P Welsh, BM Buckley, AJM de Craen, ... The Lancet 375 (9716), 735-742, 2010 | 3338 | 2010 |
Diabetes mellitus, fasting glucose, and risk of cause-specific death Emerging Risk Factors Collaboration New England Journal of Medicine 364 (9), 829-841, 2011 | 2796 | 2011 |
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ... Jama 305 (24), 2556-2564, 2011 | 1954 | 2011 |
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials KK Ray, SRK Seshasai, S Wijesuriya, R Sivakumaran, S Nethercott, ... The Lancet 373 (9677), 1765-1772, 2009 | 1891 | 2009 |
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis S Kaptoge, SRK Seshasai, P Gao, DF Freitag, AS Butterworth, ... European heart journal 35 (9), 578-589, 2014 | 790 | 2014 |
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials DI Swerdlow, D Preiss, KB Kuchenbaecker, MV Holmes, JEL Engmann, ... The Lancet 385 (9965), 351-361, 2015 | 788 | 2015 |
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65 229 participants KK Ray, SRK Seshasai, S Erqou, P Sever, JW Jukema, I Ford, N Sattar Archives of internal medicine 170 (12), 1024-1031, 2010 | 714 | 2010 |
Diabetes mellitus, fasting glucose, and risk of cause-specific death. S Rao Kondapally Seshasai, S Kaptoge, A Thompson, E Di Angelantonio, ... The New England journal of medicine 364 (9), 829-841, 2011 | 600 | 2011 |
Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials SRK Seshasai, S Wijesuriya, R Sivakumaran, S Nethercott, S Erqou, ... Archives of internal medicine 172 (3), 209-216, 2012 | 441 | 2012 |
Hypertension is a potential risk factor for vascular dementia: systematic review SI Sharp, D Aarsland, S Day, H Sønnesyn, ... International journal of geriatric psychiatry 26 (7), 661-669, 2011 | 323 | 2011 |
Glycated hemoglobin measurement and prediction of cardiovascular disease E Di Angelantonio, P Gao, H Khan, AS Butterworth, D Wormser, ... Jama 311 (12), 1225-1233, 2014 | 292 | 2014 |
Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review N Sarwar, T Aspelund, G Eiriksdottir, R Gobin, SRK Seshasai, NG Forouhi, ... PLoS medicine 7 (5), e1000278, 2010 | 237 | 2010 |
Familial hypercholesterolaemia: a global call to arms AJ Vallejo-Vaz, SRK Seshasai, D Cole, GK Hovingh, JJP Kastelein, ... Atherosclerosis 243 (1), 257-259, 2015 | 204 | 2015 |
Emerging Risk Factors Collaboration Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies N Sarwar, P Gao, SR Seshasai, R Gobin, S Kaptoge, E Di Angelantonio, ... Lancet 375 (9733), 2215-2222, 2010 | 194 | 2010 |
Effect of pitavastatin on glucose, HbA1c and incident diabetes: a meta-analysis of randomized controlled clinical trials in individuals without diabetes AJ Vallejo-Vaz, SRK Seshasai, K Kurogi, I Michishita, T Nozue, ... Atherosclerosis 241 (2), 409-418, 2015 | 148 | 2015 |
Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: rationale and design of the global EAS … AJ Vallejo-Vaz, A Akram, SRK Seshasai, D Cole, GF Watts, GK Hovingh, ... Atherosclerosis Supplements 22, 1-32, 2016 | 128 | 2016 |
Sarwar N, Sandhu MS, Ricketts SL Triglyceride Coronary Disease Genetics Consortium, ... Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H …, 2010 | 122 | 2010 |
Association of a combined measure of adherence and treatment intensity with cardiovascular outcomes in patients with atherosclerosis or other cardiovascular risk factors … K Khunti, MD Danese, L Kutikova, D Catterick, F Sorio-Vilela, M Gleeson, ... JAMA network open 1 (8), e185554-e185554, 2018 | 102 | 2018 |
Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation S Kaptoge, SRK Seshasai, L Sun, M Walker, T Bolton, S Spackman, ... The Lancet Diabetes & Endocrinology 11 (10), 731-742, 2023 | 100 | 2023 |